Royalty Pharma News and Activities

Presence

Royalty Pharma funds biopharmaceutical innovation by buying and managing royalty interests in approved and late-stage medicines. Its services support drug developers, research institutions, and investors in the healthcare market.

Royalty Pharma products and services overview:

Royalty financing
Drug royalties
Research funding
Portfolio management
Healthcare investments

Revenue: ~$3 billion

Employees: 90

Headquarters: New York, United States (USA)

Royalty Pharma is one of the...

Royalty Pharma is a company listed under the stock ticker RPRX (US).

Acquisition, funding and merger involving Royalty Pharma.

Ecora Royalties has announced the acquisition of Royalty Pharma (posted on July 1 2024).

Executives

View the org chart displaying its 37 main executives

Most searched biographies at Royalty Pharma

Popular executive movements at Royalty Pharma

Kristin Stafford, Senior Vice President and Chief Accounting Officer, has left the company (posted on April 3 2026).
Lucas Glass will join the company as Head of Artificial Intelligence in Apr. 2026 (posted on March 23 2026).
Greg Butz will join the company as Executive Vice President, Partnering and Investments in Jun. 2026 (posted on March 18 2026).

Click here to view some more movements at Royalty Pharma

Create your alert
to follow the executive moves at Royalty Pharma.